beta
/Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
Abstract

Abstract N/A

RelatedView All
Authors 18View All
CitationsView All
Citing31
Cited By-